Empasmart-Met 12.5/500 Tablets (Empagliflozin & Metformin HCL)
Empasmart-Met 12.5/500 Tablet combines Empagliflozin and Metformin to control blood sugar in adults with Type 2 diabetes, supporting weight control and reducing diabetes complications.
Introduction Of Empasmart-Met 12.5/500 Tablets
Empasmart-Met 12.5/500 Tablet is a combination of Empagliflozin (12.5 mg) and Metformin Hydrochloride (500 mg). It is prescribed to manage Type 2 Diabetes Mellitus in adults, especially when diet, exercise, or a single drug does not provide adequate blood sugar control.
Precautions Of Empasmart-Met 12.5/500 Tablets
- Monitor kidney and liver function regularly.
- Stay hydrated to avoid dehydration from empagliflozin.
- Avoid alcohol → risk of lactic acidosis with metformin.
- Not recommended in severe kidney disease.
- Consult doctor if pregnant or breastfeeding.
Uses Of Empasmart-Met 12.5/500 Tablet
- Management of Type 2 Diabetes Mellitus.
Improves glycemic control by
- Empagliflozin: Eliminates extra sugar via urine.
- Metformin: Reduces liver glucose production & improves insulin sensitivity.
Side Effects Of Empasmart-Met 12.5/500 Tablet
- Urinary tract infections
- Increased urination
- Nausea, stomach upset, diarrhea (from metformin)
- Low blood sugar (if taken with insulin/other drugs)
- Rare: lactic acidosis (medical emergency)
FAQs Of Empasmart-Met 12.5/500 Tablets
Q1: What is Empasmart-Met 12.5/500 Tablet used for?
It is prescribed to control blood sugar in adults with Type 2 diabetes when diet, exercise, or a single medicine is not enough.
Q2: How should I take this medicine?
Take the tablet with meals to reduce stomach upset. Follow the dose as advised by your doctor.
Q3: Can Empasmart-Met cause weight loss?
Yes, some patients may experience weight loss due to empagliflozin.
Q4: Can I drink alcohol while on this medicine?
No, alcohol increases the risk of lactic acidosis and dehydration.
Q5: Is it safe during pregnancy or breastfeeding?
It is generally not recommended unless your doctor advises.
Interactions Of Empasmart-Met 12.5/500 Tablets
- Insulin / Sulfonylureas: ↑ Risk of hypoglycemia.
- Diuretics: ↑ Risk of dehydration & low blood pressure.
- ACE inhibitors/ARBs: May affect kidney function.
- Alcohol: ↑ Risk of lactic acidosis.
- Other antidiabetic drugs: Dose adjustment may be required.
| Manufacturer | : | Healing Pharma |
| Trade Name | : | |
| Generic Search | : | Empagliflozin+ Metformin |
| Strength | : | 12.5 mg + 500 mg |















